Intracellular expression in pig cells of anti- α1,3galactosyltransferase single-chain FV antibodies reduces Galα1,3Gal expression and inhibits cytotoxicity mediated by anti-Gal xenoantibodies

Transplantation

Volumn 66, Issue 11, 1998, Pages 1477-1485

  Vanhove, Bernard ^a   Charreau, Beatrice ^a   Cassard, Armelle ^a   Pourcel, Christine ^a   Soulillou, Jean Paul ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CARBOHYDRATE ANALYSIS; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INACTIVATION; GRAFT REJECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES; ANTIBODIES, HETEROPHILE; CELL LINE; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; FLUORESCENT ANTIBODY TECHNIQUE; GALACTOSE; GALACTOSYLTRANSFERASES; HUMANS; SUBCELLULAR FRACTIONS; SWINE;

EID: 0032534927     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199812150-00011     Document Type: Article

References (41)

1. Galili U. Interaction of the natural anti- Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993; 14(10): 480.
2. Bouhours D, Pourcel C, Bouhours JF. Simultaneous expression by porcine aorta endothelial cells of glycolipids bearing the major epitope for human xenoreactive antibodies (Galalphal-3Gal), blood group H determinant and N-glycolylneuraminic acid. Glycoconjugate J 1996; 13: 947.
3. Thibaudeau K, Borche L, Soulillou JP, Blanchard D. Characterization of porcine platelet glycoproteins recognized by human natural "anti-gal" antibodies. Blood 1996; 87(11): 4636.
4. Sandrin MS, Fodor WL, Mouhtouris E, et al. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Med 1995; 1(12): 1261.
5. Cohney S, McKenzie IF, Patton K, et al. Down-regulation of Gal alpha(1,3)Gal expression by alphal,2-fucosyltransferase: further characterization of alpha1,2-fucosyltransferase transgenic mice. Transplantation 1997; 64(3): 495.
6. Tanemura M, Miyagawa S, Ihara Y, et al. Coexpression of N-acetylglucosaminyltransferase III (GnT-III) and alpha 2,3sialyltransferase (alpha2,3ST) gene for the reduction of xenoantigen. Fourth International Congress for Xenotransplantation. Nantes, France, 1997.
7. Sharma A, Okabe J, Birch P, et al. Downregulation of the Gal epitope in transgenic mice and pigs by expression of alpha1,2fucosyltransferase or alpha 2,6sialyltransferase. Fourth International Congress for Xenotransplantation. Nantes, France, 1997.
8. Shinkel TA, Chen CG, Salvaris E, et al. Changes in cell surface glycosylation in alpha1,3-galactosyltransferase knockout and alpha1,2-fucosyltransferase transgenic mice. Transplantation 1997; 64: 197.
9. White DJ, Calne RY. Xenotransplantation. Chirurg 1996; 67 (4): 324.
10. Byrne GW, McCurry KR, Martin MJ, McClellan SM, Platt JL, Logan JS. Transgenic pigs expressing human CD59 and decayaccelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 1997; 63(1): 149.
11. Peerschke EIB, Reid KBM, Ghebrehiwet B. Platelet activation by C1q results in the induction of aIIb/B3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity. J Exp Med 1993; 178: 579.
12. Inverardi L, Clissi B, Stolzer AL, Bender JR, Sandrin MS, Pardi R. Human natural killer lymphocytes directly recognize evolutionary conserved oligosaccharide ligands expressed by xenogeneic tissues. Transplantation 1997; 63(9): 1318.
13. Goodman DJ, vonAlbertini M, Willson A, Millan M, Bach FH. Direct activation of porcine endothelial cells by human natural killer cells. Transplantation 1995; 61(5): 763.
14. Kearns-Jonker MK, Cramer DV, Dane LA, Swensson JM, Makowka L. Human serum reactivity to porcine endothelial cells after antisense-mediated down-regulation of GpIIIa expression. Transplantation 1997; 63(4): 588.
15. Duan L, Bagasra O, Laughlin MA, Oakes JW, Pomerantz RJ. Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. Proc Natl Acad Sci USA 1994; 91(11): 5075.
16. Levy-Mintz P, Duan L, Zhang H, et al. Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. J Virol 1996; 70(12): 8821.
17. Marasco WA, Haseltine WA, Chen SY. Design, intracellular expression, and activity of a human anti-HIV-1 gp120 single chain antibody. Proc Natl Acad Sci USA 1993; 90: 7889.
18. Mhashilkar AM, Bagley J, Chen SY, Azilvay AM, Heiland DG, Marasco WA. Inhibition of HTV-1 tat-mediated LTR transactivation and HIV-infection by anti-tat single chain intrabodies. EMBO J 1995; 14: 1542.
19. Maciejewski JP, Weichold FF, Young NS, et al. Intracellular expression of antibody fragments directed against HTV reverse transcriptase prevents HIV infection in vitro. Nat Med 1995; 1(7): 667.
20. Greenman J, Jones E, Wright MD, Barclay AN. The use of intracellular single-chain antibody fragments to inhibit specifically the expression of cell surface molecules. J Immunol Methods 1996; 194; 169.
21. Yuan Q, Strauch KL, Lobb RR, Hemler ME. Intracellular single-chain antibody inhibits integrin VLA-4 maturation and function. Biochem J 1996; 318: 591.
22. Beerli RR, Weis W, Hynes NE. Autorine inhibition of the epidermal growth factor by intracellular expression of a single-chain antibody. Biochem Biophys Res Commun 1994; 204: 666.
23. Richardson JH, Sodroski JG, Waldman TA, Marasco WA. Phenotypic knock out of the high-affinity interleukin 2 receptor by intracellular single-chain antibodies against the alpha subunit of the receptor. Proc Natl Acad Sci USA 1995; 92: 3137.
24. Biocca S, Pierandrei-Amaldi P, Camponi N, Cattaneo A. Intracellular immunization with cytosolic recombinant antibodies. Biotechnology 1994; 12: 396.
25. Graus-Porta D, Beerli RR, Hynes NE. Single-chain antibody-mediated intracellular retention of Erb-B2 impairs neu differentiation factor and epidermal growth factor signaling. Mol Cell Biol 1995; 15: 1182.
26. Tavladoraki P, Benvenuto E, Trinca S, Martinis DD, Cattaneo A, Galeffi P. Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack. Nature 1993; 366: 469.
27. + thymocytes in transgenic mice expressing an anti-Lyt2.2 immunoglobulin heavy chain gene. EMBO J 1989; 8(12): 3719.
28. Vanhove B, Goret F, Soulillou JP, Pourcel C. Porcine alpha1,3-galactosyltransferase: tissue-specific and regulated expression of splicing isoforms. Biochim Biophys Acta 1997; 1356: 1.
29. Nissim A, Hoogenboom HR, Tomlinson IM, et al. Antibody fragments from a single pot phage display library as immunological reagents. EMBO J 1994; 13: 692.
30. Marks JD, Hoogenboom HR, Borniert TP, McCafferty J, Griffiths J, Winter G. By-passing immunization: human antibodies from V-gene libraries displayed on phage. J Mol Biol 1991; 222: 581.
31. Hoogenboom HR, Winter G. By-passing immunization: human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro. J Mol Biol 1992; 227: 381.
32. Berkowitz SA, Day LD. Mass, length, composition and structure of the filamentous bacterial virus fd. J Mol Biol 1976; 102: 531.
33. Tomlinson IM, Walter G, Marks JD, Llewelyn MB, Winter G. The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol 1992; 227: 776.
34. Vanhove B, Hofer-Warbinek R, Kapetanopoulos A, Hofer E, Bach FH, deMartin R. Gem, a GTP-binding protein from mitogen-stimulated T cells, is induced in endothelial cells upon activation by inflammatory cytokines. Endothelium 1997; 5: 51.
35. Andres DA, Dickerson IM, Dixon JE. Variants of the carboxylterminal KDEL sequence direct intracellular retention. J Biol Chem 1990; 265: 5952.
36. Zipfel PF, Irving SG, Kelly K, Siebenlist U. Complexity of the primary genetic response to mitogenic activation of human T cells. Mol Cell Biol 1989; 9: 1041.
37. Joziasse DH, Shaper NL, Salyer LS, VandenEijnden DH, VanderSpoel AC, Shaper JH. Alpha 1,3-Galactosyltransferase: the use of recombinant enzyme for the synthesis of alpha-galactosylated glycoconjugates. Eur J Biochem 1990; 191; 75.
38. Galili U, Tibell A, Samuelsson B, Rydberg L, Groth CG. Increased anti- Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters. Transplantation 1995; 59(11): 1549.
39. Collins BH, Parker W, Platt JL. Characterization of porcine endothelial cell determinants recognized by human natural antibodies. Xenotransplantation 1994; 1: 36.
40. Cooper MC, Koren E, Oriol R. Oligosaccharides and discordant xenotransplantation. Immunol Rev 1994; 141: 31.
41. Vandenderen BJW, Salvaris E, Romanella M, et al. Combination of DAF expression and alpha1,3-Galactosyltransferase knockout affords added protection from human complement-mediated injury. Transplantation 1997; 64(6): 882.